Dyne Therapeutics Inc (NASDAQ: DYN) on Monday, soared 41.18% from the previous trading day, before settling in for the closing price of $17.12. Within the past 52 weeks, DYN’s price has moved between $6.36 and $35.68.
Healthcare Sector giant saw their annual sales slid by -59.45% over the last five years. The company achieved an average annual earnings per share of -8.03%. With a float of $109.62 million, this company’s outstanding shares have now reached $114.34 million.
Dyne Therapeutics Inc (DYN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Dyne Therapeutics Inc is 22.94%, while institutional ownership is 71.83%. The most recent insider transaction that took place on Sep 05 ’25, was worth 35,402. In this transaction CEO & President of this company sold 2,640 shares at a rate of $13.41, taking the stock ownership to the 199,539 shares. Before that another transaction happened on Sep 04 ’25, when Company’s Chief Commercial Officer sold 894 for $13.27, making the entire transaction worth $11,863. This insider now owns 95,017 shares in total.
Dyne Therapeutics Inc (DYN) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.96 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.71) by -0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.23% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Dyne Therapeutics Inc (DYN) is currently performing well based on its current performance indicators. A quick ratio of 16.83 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.86, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.53 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Analysing the last 5-days average volume posted by the [Dyne Therapeutics Inc, DYN], we can find that recorded value of 4.1 million was better than the volume posted last year of 2.63 million. As of the previous 9 days, the stock’s Stochastic %D was 88.17%.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 95.38%, which indicates a significant increase from 93.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.86 in the past 14 days, which was higher than the 0.75 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.01, while its 200-day Moving Average is $12.22. Now, the first resistance to watch is $25.08. This is followed by the second major resistance level at $25.99. The third major resistance level sits at $27.03. If the price goes on to break the first support level at $23.13, it is likely to go to the next support level at $22.09. Should the price break the second support level, the third support level stands at $21.18.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
Market capitalization of the company is 3.44 billion based on 142,264K outstanding shares. Right now, sales total 0 K and income totals -317,420 K. The company made 0 K in profit during its latest quarter, and -110,860 K in sales during its previous quarter.
